JP2023552199A5 - - Google Patents

Info

Publication number
JP2023552199A5
JP2023552199A5 JP2023533954A JP2023533954A JP2023552199A5 JP 2023552199 A5 JP2023552199 A5 JP 2023552199A5 JP 2023533954 A JP2023533954 A JP 2023533954A JP 2023533954 A JP2023533954 A JP 2023533954A JP 2023552199 A5 JP2023552199 A5 JP 2023552199A5
Authority
JP
Japan
Prior art keywords
subject
coronavirus infection
use according
score
nucleic acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023533954A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023552199A (ja
JP7855586B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2021/061743 external-priority patent/WO2022120130A1/en
Publication of JP2023552199A publication Critical patent/JP2023552199A/ja
Publication of JP2023552199A5 publication Critical patent/JP2023552199A5/ja
Application granted granted Critical
Publication of JP7855586B2 publication Critical patent/JP7855586B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2023533954A 2020-12-03 2021-12-03 コロナウイルス感染症を発症するリスクが高い対象を特定する方法及びその治療法 Active JP7855586B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202063121067P 2020-12-03 2020-12-03
US63/121,067 2020-12-03
PCT/US2021/061743 WO2022120130A1 (en) 2020-12-03 2021-12-03 Methods of identifying subjects having an increased risk of developing a coronavirus infection and treatment thereof

Publications (3)

Publication Number Publication Date
JP2023552199A JP2023552199A (ja) 2023-12-14
JP2023552199A5 true JP2023552199A5 (https=) 2024-10-31
JP7855586B2 JP7855586B2 (ja) 2026-05-08

Family

ID=

Similar Documents

Publication Publication Date Title
Waterer et al. Septic shock and respiratory failure in community-acquired pneumonia have different TNF polymorphism associations
Plager et al. Gene transcription changes in asthmatic chronic rhinosinusitis with nasal polyps and comparison to those in atopic dermatitis
Kasela et al. Genetic and non-genetic factors affecting the expression of COVID-19-relevant genes in the large airway epithelium
CA3221576A1 (en) Diagnostic for sepsis endotypes and/or severity
Khafaei et al. Impact of IL-6 rs1800795 and IL-17A rs2275913 gene polymorphisms on the COVID-19 prognosis and susceptibility in a sample of Iranian patients
Limothai et al. Discovery and validation of circulating miRNAs for the clinical prognosis of severe dengue
US20220177982A1 (en) Methods Of Identifying Subjects Having An Increased Risk Of Developing A Coronavirus Infection And Treatment Thereof
ES2318344T3 (es) Procedimiento de diagnostico y/o de pronostico de un sindrome septico.
de Sa et al. Inflammasome Genetic Variants Are Associated with Protection to Clinical Severity of COVID‐19 among Patients from Rio de Janeiro, Brazil
JP2023523017A (ja) 感染性疾患への感受性を予測する方法および関連する処置方法
JP2023552199A5 (https=)
CN112458160B (zh) 与新型冠状病毒肺炎重症相关的11q14.2区域的多态性的检测方法、试剂盒及其应用
Vogiatzi et al. Interleukin 8 gene polymorphisms and susceptibility to restenosis after percutaneous coronary intervention
Bagheri et al. Chemokine CCL2 and its receptor CCR2 in different age groups of patients with COVID-19
ES2525881T3 (es) Procedimiento para el pronóstico de un síndrome séptico
Zhang et al. Tumor necrosis factor alpha gene polymorphisms increase susceptibility to adenovirus infection in children and are correlated with severity of adenovirus-associated pneumonia
Azarfar et al. Investigation of the relationship between monocyte chemoattractant protein 1 rs1024611 variant and severity of COVID-19
CN110100001B (zh) 评估磺胺甲基异噁唑及/或甲氧苄氨嘧啶引发药物过敏反应风险的方法
Shaker et al. Expression patterns of lncRNA MALAT-1 in SARS-COV-2 infection and its potential effect on disease severity via miR-200c-3p and SIRT1
Razavi et al. Evaluation of IFNAR2 and TYK2 transcripts’ prognostic role in COVID-19 patients: a retrospective study
Bakaros et al. Innate Immune Gene Polymorphisms and COVID-19 Prognosis. Viruses 2023, 15, 1784
US20250297314A1 (en) Determining the risk of death of a subject infected with a respiratory virus by measuring the expression level of the cd74 gene
Rodriguez et al. Genomic, Metagenomic and Transcriptomic Characterization of the Clinical Forms of COVID-19: A Comparative Cross-Sectional Study
CN114686585B (zh) Tmem65在预警和/或治疗高原病中的应用
Lee et al. Lessons Learned From Clinical Trials of Immunotherapeutics for COVID‐19